Table 1 Comparison between the drug and control groups as regards the demographic data of the enrolled patients at baseline
From: Effect of atorvastatin on inflammatory markers in hemodialysis patients
Drug group (n = 33) | Control group (n = 20) | Test | P value | |
|---|---|---|---|---|
Age (years) | 52.03 ± 11.36 | 49.30 ± 10.86 | t = 0.743* | 0.393 |
Gender | ||||
Male | 15 (45.5%) | 11 (55%) | χ2 = 0.454** | 0.501 |
Female | 18 (54.5%) | 9 (45%) | ||
Duration of dialysis (years) | 7.29 ± 5.69 | 7.55 ± 5.21 | t = 0.028* | 0.867 |
HCV-Ab positive | 10 (30%) | 9 (45%) | χ2 = 1.170** | 0.279 |
Hypertension | 19 (58%) | 13 (65%) | χ2 = 0.287** | 0.592 |
Diabetes mellitus | 4 (12%) | 6 (30%) | χ2 = 2.600** | 0.107 |